SKI Market

Indian Indices

Nifty

26,205.30 320.50
(1.24%)

Sensex

85,609.51 1,022.50
( 1.21%)

Bank Nifty

59,528.05 707.75
( 1.20%)

Nifty IT

37,364.60 537.70
( 1.46%)

Global Indices

Nasdaq

47,129.48 660.20
(1.42%)

Dow Jones

6,786.30 60.18
(0.89%)

Hang Seng

49,532.43 872.91
(1.79%)

Nikkei 225

9,602.38 67.47
(0.71%)

Forex

USD-INR

89.21 -0.39
(-0.43%)

EUR-INR

102.81 -0.34
(-0.33%)

GBP-INR

116.86 -0.46
(-0.39%)

JPY-INR

0.57 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

39.04

770.97

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.23

Back

edvenswa enterprises ltd

Balkrishna Industries consolidated net profit declines 21.26% in the September 2025 quarter

Nov 01,2025

Net profit of Balkrishna Industries declined 21.26% to Rs 273.19 crore in the quarter ended September 2025 as against Rs 346.94 crore during the previous quarter ended September 2024. Sales declined 1.09% to Rs 2393.45 crore in the quarter ended September 2025 as against Rs 2419.74 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2393.45	2419.74	-1
OPM %	21.36	23.96	-
PBDT	549.89	629.08	-13
PBT	357.30	462.64	-23
NP	273.19	346.94	-21

26,205.30 320.50 (1.24%)

85,609.51 1,022.50 ( 1.21%)

59,528.05 707.75 ( 1.20%)

37,364.60 537.70 ( 1.46%)

47,129.48 660.20 (1.42%)

6,786.30 60.18 (0.89%)

49,532.43 872.91 (1.79%)

9,602.38 67.47 (0.71%)

89.21 -0.39 (-0.43%)

102.81 -0.34 (-0.33%)

116.86 -0.46 (-0.39%)

0.57 0.00 (-0.65%)